Trial Profile
Combined use of rivaroxaban and tranexamic acid for hemorrhage and thrombosis management in spine surgery
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2021
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Tranexamic acid (Primary)
- Indications Haemorrhage; Thrombosis; Venous thromboembolism
- Focus Therapeutic Use
- 04 Jun 2018 New trial record